Maryland House Bill 134 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 15 2020 - 25% progression, died in committee
Action: 2020-01-28 - Hearing 2/06 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to limit the cumulative amount a covered individual is required to pay on copayment or coinsurance for a covered prescription insulin drug to no more than $100, regardless of the amount or type of insulin needed to fill the covered individual's prescriptions; applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2021; etc.

Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance

Del. Kirill Reznik [D]

Del. Kriselda Valderrama [D]

Date	Chamber	Action
2020-01-28	House	Hearing 2/06 at 1:00 p.m.
2020-01-15	House	First Reading Health and Government Operations

Chapter	Article	Section	Citation Type	Statute Text
Insurance	15	822.1	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0134?ys=2020RS
Text	https://mgaleg.maryland.gov/2020RS/bills/hb/hb0134f.pdf